Formed in 2017, SCA Robotics is an early stage, commercial Precision Analytics company developing artificial intelligence (AI) diagnostic solutions proven to improve the identification, prediction, and treatment of patients with cancer diabetes and heart disease. SCA's diagnostic and clinical analysis solutions are based on big data, deep learning and medical imaging analysis (computer vision) to investigate clinical and medical imaging data such as X-rays, CT scans, Nuclear medicine scans, MRI scans, Ultrasound. SCA's has proven expertise in developing AI solutions related to metastatic and nonmetastatic tumor prediction, closed-loop glucose monitoring (for medical devices) and clinical and MRI imaging data for cases requiring valve replacement in the heart (TAVI). SCA's mission is to make AI and machine learning work for healthcare building precision medicine solutions to save human lives drastically improves patient initiatives as well as protocol and business operations. All SCA products are delivered via software-as-a-solution (SaaS). -SCA Robotics is a strategic partner to a major cancer research facility, the City of Hope, to pioneer and develop a "Radiographical Assessment of Brain and Spinal Tumors using Predictive Artificial Intelligence Modeling." -SCA was selected and attended the prestigious American Diabetes Association's 23rd Annual Leaders Forum Healthtech Showcase in November 2018. -SCA also filed a provisional USPTO application for a “precision medical treatment and predictive modeling platform for assessing diabetes and neurological and cardiopulmonary analysis” Our mission is to make an impact on health through artificial intelligence and machine learning tools.
